Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]
Conditions
Interventions
None listed
Sponsors
Manjusha Vagal
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patient diagnosed with Acute lymphoblastic leukaemia. (2) Patient willing to take entire treatment at Tata memorial hospital. (3) Patient willing to follow-up for periodic assessments at Tata Memorial Hospital.
Exclusion criteria
Exclusion criteria: (1) Patients presenting with neurological deficit at baseline assessment. (2) Pre-morbid neuromuscular disorders (such as traumatic brain injury or cerebral palsy) (3) Childhood diabetes mellitus induced peripheral neuropathy. (4) Paediatric cancer patients other than Acute Lymphoblastic Leukaemia (5) Patients unable to complete
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To understand the incidence, of sensory and motor symptoms in Acute Lymphoblastic Leukaemia patients receiving chemotherapy involving vincristine. 2. To understand the course of presentation of sensory and motor symptoms in Acute Lymphoblastic Leukaemia patients receiving chemotherapy involving vincristine Timepoint: 1 Baseline assessment followed by weekly assessments during induction phase of administration of vincristine and then monthly assessments until completion of intensive phase of chemotherapy as per protocol | — |
Secondary
| Measure | Time frame |
|---|---|
| 3. To examine and record impact of vincristine on Function using Canadian occupational performance measure 4. To examine and record impact of vincristine on Play participation using Takata play history 5. To examine and record impact of vincristine on Schooling abilities using a departmental semi-structured interview Timepoint: 1 Baseline assessment followed by weekly assessments during induction phase of administration of vincristine and then monthly assessments until completion of intensive phase of chemotherapy as per protocol | — |
Countries
India
Contacts
Public ContactSaumya Dixit
Tata Memorial Hospital
Outcome results
None listed